Cargando…
Sorafenib inhibits invasion of multicellular organoids that mimic Lymphangioleiomyomatosis nodules
Lymphangioleiomyomatosis (LAM) is a debilitating, progressive lung disease with few therapeutic options, largely due to a paucity of mechanistic knowledge of disease pathogenesis. Lymphatic endothelial cells (LECs) are known to envelope and invade clusters of LAM-cells, comprising of smooth muscle α...
Autores principales: | Koc-Gunel, Sinem, Gautam, Lalit K., Calvert, Ben A., Murthy, Shubha, Harriott, Noa C., Nawroth, Janna C., Zhou, Beiyun, Krymskaya, Vera P., Ryan, Amy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312665/ https://www.ncbi.nlm.nih.gov/pubmed/37398026 http://dx.doi.org/10.1101/2023.06.12.544372 |
Ejemplares similares
-
A Case of Lymphangioleiomyomatosis (LAM) of the Lung in a Patient with a History of Breast Cancer
por: Koc-Günel, Sinem, et al.
Publicado: (2019) -
CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis
por: Evans, Jilly Frances, et al.
Publicado: (2021) -
Wild Type Mesenchymal Cells Contribute to the Lung Pathology of Lymphangioleiomyomatosis
por: Clements, Debbie, et al.
Publicado: (2015) -
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis
por: Evans, Jilly F., et al.
Publicado: (2023) -
Generating Functional Multicellular Organoids from Human Placenta Villi
por: Huang, Lijun, et al.
Publicado: (2023)